Whether the patient is a combat soldier or a football player, doctors sometimes struggle to identify victims of traumatic brain injury.
BrainScope, based in Bethesda, Maryland, is one step closer to easing that process through its Ahead 100 device. The company announced on Wednesday that it earned United States Food and Drug Administration (FDA) clearance for the device.
The device is designed for patients between 18 and 80 years old who have suffered closed head injuries within 24 hours. The device uses a patient’s electroencephalograph to interpret the structural condition of his or her brain. The device helps doctors decide if a patient should receive a Computerized Tomography (CT) scan or other treatment.